| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |